Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication.

ABSTRACT:

Background

Financial conflicts of interest (FCOI) are known to be prevalent in medicine. Authorship of pivotal trials reap non-financial benefits including publication productivity that can be used for assessment of tenure positions and promotion. The purpose of this investigation was to quantify the prevalence and discordance of academic trial author (authors) FCOI in industry-sponsored drug trials that were initially presented as oral abstracts and subsequently resulted in a peer-reviewed publication.

Methods

Oral abstracts from the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting that were subsequently published were identified. Studies that were non-industry sponsored, non-adult, or non-therapeutic trials were excluded. Studies that did not have a subsequ

SUBMITTER: Weiss GJ 

PROVIDER: S-EPMC6375255 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature